John Libbey Eurotext

Epileptic Disorders

The Educational Journal of the

Quality of life after vagal nerve stimulator insertion Volume 11, numéro 1, March 2009

Auteurs
Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Adult and Pediatric Epilepsy Program, American University of Beirut Medical Center, Department of Surgery, Division of Neurosurgery, American University of Beirut Medical Center, Beirut, Lebanon, Department of Neurosurgery, St. Luke’s Episcopal Hospital and Baylor College of Medicine Faculty Center, Texas, USA, Division of Pediatric Neurology, Duke University School of Medicine, Durham, USA
  • Mots-clés : quality of life, vagal nerve stimulator, epilepsy surgery, drug resistance
  • DOI : 10.1684/epd.2009.0244
  • Page(s) : 67-74
  • Année de parution : 2009

Aim. Assess quality-of-life after vagal nerve stimulation and determine patient characteristics associated with improvement in quality-of-life. Methods. Sixteen patients (11 children, 5 adults) who had vagal nerve stimulation at our center were studied. Quality-of-life was assessed pre- and post-vagal nerve stimulation using the Quality-of-Life in Childhood Epilepsy questionnaire for children and the Epilepsy Surgery Inventory-55 for adults. Results. Sixteen patients who did not qualify for resective surgery were included; seven (43.75%) were males and 9 (56.25%) were females. Mean age at onset of seizures was 3.96 ± 4.00 years and at surgery was 15.78 ± 10.78. Follow-up time was 1.26 ± 0.92 years. Fourteen patients (87.5%) were mentally retarded. Ten (62.5%) had cryptogenic etiology and 6 patients (37.5%) symptomatic etiology. Fifty percent had localization-related epilepsy. Six of 7 patients with generalized cryptogenic etiology (85.71%) had Lennox-Gastaut syndrome. Seizures dropped from 122.31 ± 159.49 to 67.84 ± 88.22 seizures/month. Seizure reduction (> 50%) correlated with improvement in total quality-of-life (p = 0.034). Post-vagal nerve stimulation, the total group scored significantly higher in the social domain (p = 0.039). In patients with localization-related epilepsy, significant improvements were detected in the social domain (p = 0.049) and in total quality-of-life (p = 0.042). Conclusion. Despite a diverse and small population size, we observed significant improvements in the social domain 1.26 years post-vagal nerve stimulation. In addition, there was an improvement in total quality-of-life amongst patients with partial seizures. Finally, seizure reduction was associated with quality-of-life improvement. Our results support previous studies from the West reporting improvement in quality-of-life following vagal nerve stimulation, contradict those studies that did not show such differences, and are the first coming from a developing country.